Episode
What's the Metholodology behind Clinical Guidelines?
- Published
- Jun 26, 2026
- Duration seconds
- 720
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/diabetes-insights-breakthroughs-and-innovators-7109701/episodes/what-s-the-metholodology-behind-clinical-guidelines/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/diabetes-insights-breakthroughs-and-innovators-7109701/what-s-the-metholodology-behind-clinical-guidelines.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, Prof. Thomas Karagiannis and Dr Francesco Zaccardi take us behind the scenes of clinical guideline development at EASD. As methodologists involved in creating the first EASD clinical guidelines, they explain how rigorous evidence review, transparent processes and careful management of conflicts of interest help ensure recommendations are trustworthy and evidence-based. The discussion explores the newly developed guideline on diabetes distress, upcoming guidance on continuous glucose monitoring in type 2 diabetes, and future recommendations on diabetes prevention. Along the way, Thomas and Francesco highlight the importance of patient involvement, the role of systematic reviews and meta-analyses, and the emerging opportunities for artificial intelligence in guideline development. Join us for an insightful look at the work that transforms scientific evidence into practical recommendations that can shape diabetes care across Europe and beyond.